CVE-2025-24020

Public Exploit
WeGIA Open Redirect vulnerability

Description

WeGIA is a Web manager for charitable institutions. An Open Redirect vulnerability was identified in the `control.php` endpoint of versions up to and including 3.2.10 of the WeGIA application. The vulnerability allows the `nextPage` parameter to be manipulated, redirecting authenticated users to arbitrary external URLs without validation. The issue stems from the lack of validation for the `nextPage` parameter, which accepts external URLs as redirection destinations. This vulnerability can be exploited to perform phishing attacks or redirect users to malicious websites. Version 3.2.11 contains a fix for the issue.

Category

4.8
CVSS
Severity: Medium
CVSS 4.0 •
CVSS 3.1 •
EPSS 0.06%
Vendor Advisory github.com
Affected: LabRedesCefetRJ WeGIA
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-24020?
CVE-2025-24020 has been scored as a medium severity vulnerability.
How to fix CVE-2025-24020?
To fix CVE-2025-24020, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-24020 being actively exploited in the wild?
It is possible that CVE-2025-24020 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-24020?
CVE-2025-24020 affects LabRedesCefetRJ WeGIA.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.